News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Celebrating a Successful Match Day at Weill Cornell Medicine

Student on Match Day

Video of Match Day 2026 at Weill Cornell Medicine

Taylor Lis couldn’t imagine being anything other than a doctor. Meeting new people every day and helping them live healthier lives is a deep passion of hers—one that has motivated her through the past four years as a medical student at Weill Cornell Medical College.

Now, on National Match Day, Lis learned where she’ll complete her residency training: Children’s Hospital of Pennsylvania for pediatrics, her first choice.

“You think about Match Day from the day you get into med school, the big cornerstone culminating entire years of preparation, to then get to go on and become a real doctor and train at an amazing institution,” Lis said. “It's really surreal to be here and I'm super excited.”

Lis and her fellow classmates in the Class of 2026 learned on March 20 where they will be doing their internship and residency training—setting the stage for the next several years of their medical careers and lives.

Unusual Tumor Cells May Be Overlooked Factors in Advanced Breast Cancer

immunofluorescent image of dual-positive cells

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The findings highlight the potential importance of these under-studied cells in breast cancer progression.

headshot of a woman

Dr. Carolina Reduzzi

Circulating tumors cells are breakaway tumor cells that can seed secondary tumors (metastases) and are commonly detected in the blood of patients with cancer. Dual-positive cells are circulating cells that bear both tumor-cell and immune-cell markers, and are thought to be hybrid cells resulting from rare fusions of tumor cells with immune cells. Recent studies have linked DP cells’ presence in patients’ blood to worse outcomes in melanoma and pancreatic cancer.

New Model May Predict Preeclampsia in Late Pregnancy

pregnant woman having blood pressure taken

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.